{"disease":{"id":"arthritic-pain","name":"Arthritic Pain","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"levomenthol","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"LEVOMENTHOL","company_name":"","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 8","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"camphor","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alphanon","generic_name":"CAMPHOR","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"camphor","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"capsaicin","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qutenza","generic_name":"CAPSAICIN","company_name":"Averitas","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 1","drug_class":"capsaicin","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"acetylsalicylic-acid","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norgesic","generic_name":"acetylsalicylic acid","company_name":"Endo","drug_phase":"marketed","molecular_target":"reticular formation (brain stem)","drug_class":"centrally acting muscle relaxant with anticholinergic properties","quality_score":82,"revenue":null,"mechanism":"Orphenadrine citrate centrally acts on brain stem to selectively block facilitatory reticular functions."},{"drug_id":"methyl-salicylate","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"METHYL SALICYLATE","company_name":"Hisamitsu Pharm Co","drug_phase":"marketed","molecular_target":"","drug_class":"methyl salicylate","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"paracetamol","indication_name":"Arthritic Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Acetaminophen","generic_name":"Paracetamol","company_name":"Polymedica","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 4","drug_class":"acetaminophen","quality_score":60,"revenue":null,"mechanism":"Acetaminophen works by blocking pain signals in the brain."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07361198","title":"Percutaneous Transcatheter Genicular Embolization in Osteoarthritis","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.","has_results":false}],"total":1},"guidelines":[{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains. Note: Aspirin is also indicated for myocardial infarction, but specific dosing and usage should be discussed with a healthcare provider.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"aspirin","guideline_body":"FDA label","recommendation":"For the temporary relief of minor aches and pains.","line_of_therapy":"any","evidence_grade":"C","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"acetylsalicylic-acid","guideline_body":"FDA label","recommendation":"Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"paracetamol","guideline_body":"FDA label","recommendation":"temporarily relieves minor pain of arthritis","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}